Cefepime and amikacin synergy against a cefotaxime-susceptible strain of Enterobacter cloacae in vitro and in vivo

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue 3, 1997, Pages 363-369

  Mimoz, Olivier ^a   Jacolot, Anne ^b   Padoin, Christophe ^b   Caillon, Jocelyne ^c   Louchahi, Kamel ^b   Tod, Michel ^b   Samii, Kamran ^a   Petitjean, Olivier ^b  

^a BICÊTRE HOSPITAL   (France)

^b AVICENNE HOSPITAL   (France)

^c CHU de Nantes   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; CEFEPIME; CEPHALOSPORIN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL COUNT; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG POTENTIATION; ENTEROBACTER CLOACAE; EXPERIMENTAL MODEL; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PNEUMONIA; RAT;

AMIKACIN; ANIMALS; ANTI-BACTERIAL AGENTS; CEFOTAXIME; CEPHALOSPORINS; DRUG RESISTANCE, MICROBIAL; DRUG SYNERGISM; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTIONS; KIDNEY; MALE; MICROBIAL SENSITIVITY TESTS; PNEUMONIA, BACTERIAL; RATS; RATS, WISTAR;

EID: 0030901032     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.3.363     Document Type: Article

References (31)

1. Schaberg, D. R., Culver, D. H. & Gaynes, R. P. (1991). Major trends in the microbial etiology of nosocomial infection. American Journal of Medicine 91, Suppl. 3B, 72S-5S.
2. Vincent, J. L. (1994). Preliminary results of the European Study on Prevalence of Infection in Intensive Care. In Update in intensive Care and Emergency Medicine (Vincent, J. L, Ed.), pp. 222-7. Springer-Verlag, Berlin.
3. Péchère, J. C., Marchou, B., Michéa-Hamzehpour, M. & Auckenthaler, R. (1986). Emergence of resistance after therapy with antibiotics used alone or combined in a murine model. Journal of Antimicrobial Chemotherapy 17, Suppl. A 11-8.
4. Marchou, B., Michéa-Hamzehpour, M., Lucain, C. & Péchère, J, C. (1987). Development of β-lactam-resistant Enterobacter cloacae in mice. Journal of Infectious Diseases 156, 369-73.
5. Marchou, B., Bellido, F., Charnas, R., Lucain, C. & Péchère, J. C. (1987). Contribution of β-lactamase hydrolysis and outer membrane permeability to ceftriaxone resistance in Enterobacter cloacae. Antimicrobial Agents and Chemotherapy 31, 1589-95.
6. Phelps, D. J., Carlton, D. D., Farrell, C. A. & Kessler, R. E. (1986). Affinity of cephalosporins for β-lactamases as a factor in antibacterial efficacy. Antimicrobial Agents and Chemotherapy 29, 845-8.
7. Bellido, F., Péchère, J. C. & Hancock, R. E. W. (1991). Novel method for measurement of outer membrane permeability to new β-lactams in intact Enterobacter cloacae cells. Antimicrobial Agents and Chemotherapy 35, 68-72.
8. Péchère, J. C. & Vladoianu, I. R. (1992). Development of resistance during ceftazidime and cefepime therapy in a murine peritonitis model. Journal of Antimicrobial Chemotherapy 29, 563-73.
9. Drugeon, H., Legallou, F, & Caillon, J. (1991). Méthodes d'études de l'activité bactéricide. In Bactéricidie. Aspects Théoriques et Thérapeutiques (Courvalin, P., Drugeon, H., Flandrois, J. P. & Goldstein, F., Eds), pp. 113-26. Maloine, Paris.
10. Craig, W. A., Redington, J. & Ebert, S. C. (1991). Pharmaco-dynamics of amikacin in vitro and in mouse thigh and lung infections. Journal of Antimicrobial Chemotherapy 27, Suppl. C, 29-40.
11. Barbhaiya, R. H., Forgue, S. T., Shyu, W. C., Papp, E. A. & Pittman, K. A. (1987). High-pressure liquid Chromatographic analysis of BMY-28142 in plasma and urine. Antimicrobial Agents and Chemotherapy 31, 55-9.
12. Pennington, J. E. & Stone, R. M. (1979). Comparison of antibiotic regimens for treatment of experimental pneumonia due to Pseudomonas. Journal of Infectious Diseases 140, 881-9.
13. Fantin, B. & Carbon, C. (1992). In vivo synergism: contribution of animal models. Antimicrobial Agents and Chemotherapy 36, 907-12.
14. Nix, D. E., Goodwin, D., Peloquin, C. A., Rotella, D. L. & Schentag, J. J. (1991). Antibiotic tissue penetration and its rele- vance: models of tissue penetration and their meaning. Antimicro- bial Agents and Chemotherapy 35, 1947-52.
15. Craig, W. A., Leggett, J., Totsuka, K. & Vogelman, B. (1988). Key pharmacokinetlc parameters of antibiotic efficacy in experimental animal infections. Journal of Drug Development 1, Suppl. 3, 7-15.
16. Lortholary, O., Tod, M., Cohen, Y. & Petitjean, O. (1995). Aminoglycosides. Medical Clinics of North America 79, 761-87.
17. Leggett, J. E., Fantin, B., Ebert, S., Totsuka, K., Vogelman, B., Calame, W. et al. (1989). Comparative antibiotic dose - effect relations at several dosing intervals in murine pneumonitis and thigh-infection models. Journal of Infectious Diseases 159, 281-92.
18. Rouby, J, J., Martin de Lasalle, E., Poete, P., Nicolas, M. H., Bodin, L, Jarlier, V. et al. (1992). Nosocomial bronchopneumonia in the critically ill. Histologic and bacteriologic aspects. American Review of Respiratory Disease 146, 1059-66.
19. Gerber, A. U., Greter, U., Segessenmann, C. & Kozak, S. (1993). The impact of pre-treatment interval on antimicrobial efficacy in a biological model. Journal of Antimicrobial Chemotherapy 31, Suppl. D, 29-39.
20. Roosendaal, R., Bakker-Woudenberg, I. A. J. M., van den Berghe-van Raffe, M., Vink-van den Berg, J. C. & Michel, M. F. (1991). Impact of the duration of infection on the activity of ceftazidime, gentamicin and ciprofloxacin in Klebsiella pneumoniae and septicemia in leukopenic rats. European Journal of Clinical Microbiology and Infectious Diseases 10, 1019-25.
21. Cozens, R. M., Tuomanen, E., Tosch, W., Zak, O., Suter, J. & Tomasz, A. (1986). Evaluation of the bactericidal activity of β-lactam antibiotics on slowly growing bacteria cultured in the chemostat. Antimicrobial Agents and Chemotherapy 29, 797-802.
22. Tuomanen, E., Cozens, R., Tosch, W., Zak, O. & Tomasz, A. (1986). The rate of killing of Escherichia coll by beta-lactam antibiotics is strictly proportional to the rate of bacterial growth, Journal of General Microbiology 132, 1297-304.
23. Davis, B. D. (1987). Mechanism of bactericidal action of aminoglycosides. Microbiological Reviews 51, 341-50.
24. Bodey, G. P., Ho, D. H. & LeBlanc, B. (1985). In vitro studies of BMY-28142, a new broad-spectrum cephalosporin. Antimicrobial Agents and Chemotherapy 27, 265-9.
25. Kapusnik, J. E., Hackbarth, C. J., Chambers, H. F., Carpenter, T. & Sande, M. A. (1988). Single, large, daily dosing versus intermittent dosing of tobramycin for treating experimental Pseudomonas pneumonia. Journal of Infectious Diseases 158, 7-12.
26. Kobasa, W. D. & Kaye, D. (1983). Aztreonam, cefoperazone, and gentamicin in the treatment of experimental Enterobacter aerogenes endocarditis in rabbits. Antimicrobial Agents and Chemotherapy 24, 321-4.
27. Levison, M. E. & Kobasa, W. D. (1984). Mezlocillin and ticarcillin alone and combined with gentamicin in the treatment of experimental Enterobacter aerogenes endocarditis. Antimicrobial Agents and Chemotherapy 25, 683-6.
28. Scott, R. E. & Robson, H. G. (1976). Synergistic activity of carbenicillin and gentamicin in experimental Pseudomonas bacteremia in neutropenic rats. Antimicrobial Agents and Chemotherapy 10, 646-51.
29. Klastersky, J., Meunier-Carpentier, F. & Prevost, J. M. (1977). Significance of antimicrobial synergism for the outcome of Gram negative sepsis. American Journal of the Medical Sciences 273, 157-67.
30. Andriole, V. T. (1974). Antibiotic synergy in experimental infection with Pseudomonas. II. The effect of carbenicillin, cephaiothin, or cephanone combined with tobramycin or gentamicin. Journal of Infectious Diseases 129, 124-33.
31. Gordin, F. M., Rusnak, M. G. & Sande, M. A. (1987). Evaluation of combination chemotherapy in a lightly anesthetized animal model of Pseudomonas pneumonia. Antimicrobial Agents and Chemotherapy 31, 398-403.